Recombinant anti-Aβ42 intrabody in fusion with HIV Tat works within cells and is directed against intracellur Aβ42, expressed in E. coli cells. The intrabodies, one with an endoplasmic reticulum (ER) targeting signal and one devoid of a targeting sequence, were assessed in cells harboring a doxycycline (Dox)-regulated mutant human amyloid precursor protein Swedish mutant (hAPPswe) transcription unit for their abilities to prevent Aβ peptide egress.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-25 | Recombinant Anti-human Aβ42 Antibody | WB, FC, FuncS | IgG |
MHH-25 | Recombinant Human Anti-human Aβ42 Antibody | FC, WB, FuncS | IgG |
FAMAB-0160-CN | Human Anti-Aβ42 Recombinant Antibody (clone scFv59) | WB, ELISA, IF, IHC | Human IgG |
HPAB-0586-FY | Human Anti-Aβ42 Recombinant Antibody (clone M06) | DB, ELISA | Human IgG |
HPAB-2064-FY | Human Anti-Aβ42 Recombinant Antibody (clone 8F5) | Neut, ELISA, DB, IF | Human IgG |
There are currently no Customer reviews or questions for IAB-B042(T). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.